Patent details

Basic Information

Publication number:

EP2874649

PCT Application Number:

US2013048571

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP138100185

PCT Publication Number:

WO2014005019

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CELLS FOR PRODUCING RECOMBINANT IDURONATE-2-SULFATASE

French Title of Invention:

CELLULES POUR L'OBTENTION D'IDURONATE-2-SULFATASE RECOMBINANTE

German Title of Invention:

VERFAHREN ZUR HERSTELLUNG REKOMBINANTER IDURONAT-2-SULFATASE

SPC Number:

Dates

Filing date:

28/06/2013

Grant date:

02/01/2019

EP Publication Date:

27/05/2015

PCT Publication Date:

03/01/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

02/01/2019

EP B1 Publication Date:

02/01/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

28/06/2019

Expiration date:

28/06/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

26/12/2018

 

 

Name:

Shire Human Genetic Therapies, Inc.

Address:

300 Shire Way, Lexington MA 02421, United States (US)

Inventor

1

Name:

BOLDOG, Ferenc

Address:

United States (US)

2

Name:

HEARTLEIN, Michael

Address:

United States (US)

Priority

Priority Number:

201261666719 P

Priority Date:

29/06/2012

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/46; C07K 1/00; C12P 21/06;

Publication

European Patent Bulletin

Issue number:

201901

Publication date:

02/01/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages